Successful brentuximab vedotin and nivolumab therapy of multiply refractory diffuse large B-cell lymphoma with Hodgkin features

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Access to Document

@article{e7f6ac4686494ae5a6754faaf6b9077e,

title = "Successful brentuximab vedotin and nivolumab therapy of multiply refractory diffuse large B-cell lymphoma with Hodgkin features",

author = "Victor Zibara and Filiz Sen and Michael Scordo and Lorenzo Falchi",

year = "2022",

doi = "10.1080/10428194.2022.2113528",

language = "English",

volume = "63",

pages = "3241--3244",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Taylor and Francis Ltd.",

number = "13",

}

TY - JOUR

T1 - Successful brentuximab vedotin and nivolumab therapy of multiply refractory diffuse large B-cell lymphoma with Hodgkin features

AU - Zibara, Victor

AU - Sen, Filiz

AU - Scordo, Michael

AU - Falchi, Lorenzo

PY - 2022

Y1 - 2022

UR - https://www.scopus.com/pages/publications/85138326330

U2 - 10.1080/10428194.2022.2113528

DO - 10.1080/10428194.2022.2113528

M3 - Letter

C2 - 36120859

AN - SCOPUS:85138326330

SN - 1042-8194

VL - 63

SP - 3241

EP - 3244

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 13

ER -